LGBT Cancer Project

Therapeutic Areas: Oncology

Polyps Clinical Trials

A listing of Polyps medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Fresno California 93720

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Walnut Creek California 94598

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Colorado

UPDATED

Colorado Springs Colorado 80909

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Denver Colorado 80230

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Connecticut

UPDATED

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Missouri

UPDATED

Kansas City Missouri 64115

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

North Carolina

UPDATED

North Charleston North Carolina 29420

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

South Carolina

UPDATED

Orangeburg South Carolina 29118

A Phase 3 clinical study for patients with Polyps, Nasal

Utah

UPDATED

Salt Lake City Utah 84132

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Virginia

UPDATED

Fairfax Virginia 22030

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Washington

UPDATED

Bellevue Washington 98225

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Wisconsin

UPDATED

Milwaukee Wisconsin 53219

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Australia

UPDATED

Clayton Victoria 3169

A Phase 3 clinical study for patients with Polyps, Nasal

Canada

UPDATED

London Ontario N6A 4V2

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Montreal Quebec H2W 1T8

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Montreal Quebec H3G 1L5

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Québec G1S 4L8

A Phase 3 clinical study for patients with Polyps, Nasal

Germany

UPDATED

Berlin 13353

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Dresden Sachsen 01307

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Dresden Sachsen 01139

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Muenchen Bayern 81675

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Wiesbaden Hessen 65183

A Phase 3 clinical study for patients with Polyps, Nasal

Japan

UPDATED

Hiroshima-Shi

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Inzai-Shi

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Meguro-Ku

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Minato-Ku

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Korea, Republic of

UPDATED

Seongnam-si, Gyeonggi-do 13620

A Phase 3 clinical study for patients with Polyps, Nasal

Mexico

UPDATED

Chihuahua 31200

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Chihuahua 31000

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Durango 34080

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Guadalajara 44100

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Monterrey 64460

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Russian Federation

UPDATED

Yaroslavl 150003

A Phase 3 clinical study for patients with Polyps, Nasal

Turkey

UPDATED

Ankara 06100

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Ankara 06520

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Ankara 06500

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Aydin 09100

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Bursa 16059

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Istanbul 34390

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Istanbul 34360

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Istanbul 34373

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Istanbul 34764

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Istanbul 34010

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Izmir 35340

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Izmir 35100

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Rize 53100

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps